Can the battle against cancer be lost? From a diagnostic and therapeutic point of view, the progress made in recent years has been irrefutable. The outlook is less rosy when considering the global mortality rate, in the light of the distribution of the most effective and advanced resources used to fight the disease. 75% of anticancer drugs are consumed in Europe, North America and Japan, while as many as 30 other countries in the world do not even have a single radiotherapy device.
Can the battle against cancer be lost? From a diagnostic and therapeutic point of view, the progress made in recent years has been irrefutable. The outlook is less rosy when considering the global mortality rate, in the light of the distribution of the most effective and advanced resources used to fight the disease. 75% of anticancer drugs are consumed in Europe, North America and Japan, while as many as 30 other countries in the world do not even have a single radiotherapy device.
ECCO (European Cancer Congress) 2017 - Amsterdam
What is needed to win the battle against cancer
Cosa manca per vincere la battaglia contro il cancro
Pediatric cancer: similar care level across Europe?
The uro-oncological highlights of ECCO 2017
Different treatment options in relapsed ovarian cancer
Cancro: la pianificazione del trattamento deve essere multidisciplinare
Cancer: treatment planning must be multidisciplinary
Oncologic surgery in the elderly is underutilized
La chirurgia oncologica nell'anziano è sottoutilizzata
Pembrolizumab is effective against mucosal melanoma
Breast cancer: conservative therapy vs mastectomy
La personalizzazione della chemioterapia nel paziente anziano
The Dutch protocol for the standardization of cancer treatments
Cancer care standardization: the role of SONCOS
